Pientzehuang Pharmaceutical approves all resolutions at 2024 AGM

Zhangzhou Pientzehuang Pharmaceutical (SSE:600436) announced the successful passage of all resolutions at its 2024 Annual General Meeting held on June 20, 2025. The meeting, conducted through a combination of online and on-site voting, saw the participation of shareholders representing 58.5358% of the company's total voting shares, equivalent to 353,157,040 shares. Key resolutions approved include the 2024 Board of Directors Work Report, the 2024 Supervisory Board Work Report, the appointment of the accounting firm and determination of its remuneration, the 2024 Annual Report and Summary, the 2024 financial statements and 2025 financial budget, the 2025 compensation for directors, supervisors, and senior management, and the 2024 profit distribution plan. All resolutions were passed with over 99% approval from shareholders, and the meeting was deemed compliant with relevant laws and the company's articles of association by legal counsel.